All Pharma News
Cyxone Streamlines Manufacturing Process for Rabeximod

Cyxone Streamlines Manufacturing Process for Rabeximod
CONTRACT PHARMA
09 Mar 2023
Share Share
Nomination committee appointed for Cyxone Annual General Meeting 2023

Nomination committee appointed for Cyxone Annual General Meeting 2023
IPOHUB
08 Nov 2022
Share Share
Cyxone will leverage IND and use FDA pre-review for Covid-19 phase 2 trial

Cyxone will leverage IND and use FDA pre-review for Covid-19 phase 2 trial
CISION
24 Sep 2021
Share Share
Cyxone & Medical University of Vienna announce collaboration to study T20K

Cyxone & Medical University of Vienna announce collaboration to study T20K
CISION
01 Jul 2021
Share Share
Cyxone Initiates Feasibility Preclinical Studies to Multiple Sclerosis

Cyxone Initiates Feasibility Preclinical Studies to Multiple Sclerosis
CISION
06 May 2021
Share Share
Cyxone reports first Covid-19 screened in Ph2 trial of Rabeximod

Cyxone reports first Covid-19 screened in Ph2 trial of Rabeximod
PRNEWSWIRE
15 Jan 2021
Share Share
Cyxone has filed an IND in the US with Rabeximod following positive feed-back

Cyxone has filed an IND in the US with Rabeximod following positive feed-back
PRNEWSWIRE
15 Dec 2020
Share Share
Cyxone to begin Phase II trial of oral Covid-19 drug

Cyxone to begin Phase II trial of oral Covid-19 drug
CLINICALTRIALSARENA
09 Dec 2020
Share Share
Cyxone receives regulatory approval to initiate a clinical Phase 2 study

Cyxone receives regulatory approval to initiate a clinical Phase 2 study
PRNEWSWIRE
08 Dec 2020
Share Share
Cyxone files patent application to extend exclusivity of Rabeximod

Cyxone files patent application to extend exclusivity of Rabeximod
PRNEWSWIRE
10 Nov 2020
Share Share